0000000000458445

AUTHOR

Lodato G.

showing 3 related works from this author

Electroretinographic oscillatory potentials in insulin-dependent diabetes patients: A long-term follow-up.

2002

Purpose: The aim of this research was to study the relevance of long-term follow-up of electroretinographic oscillatory potentials (OPs) in predicting the onset of minimal non-proliferative diabetic retinopathy in insulin-dependent diabetes patients. Methods: A total of 80 insulin-dependent diabetics, with normal fundi and normal OPs at first examination, were followed prospectively for 10 years. Oscillatory potentials were measured and fundus examinations performed once or twice per year. Results: During follow-up, 35% of patients developed diabetic retinopathy after a mean disease duration of 12 ± 2 years. A decrease in OP amplitudes was seen in 46% of this group, but reductions were also…

Survival curvesAdultMaleDiabetic RetinopathyAdolescentSettore MED/30 - Malattie Apparato VisivoElectroretinogramRetinaOscillatory potentialsDiabetes Mellitus Type 1OscillometryElectroretinographyHumansFemaleProspective StudiesChildLong-term follow-upFollow-Up StudiesActa ophthalmologica Scandinavica
researchProduct

Day surgery for cataract: descriptive survey in central and southern Italy

2005

Abstract Day surgery has rapidly gained worldwide acceptance especially in the field of ophthalmology. In Italy, cataract surgery is the most frequently performed surgical procedure, even on account of the ageing of the population. This procedure represents a very sensitive indicator of trends in day surgery hospitalizations and of political-managerial situations in the different regional healthcare realities. The aim of this study was to evaluate the diffusion of cataract day surgery in ophthalmology centres/divisions in central and southern Italy in 2003. A questionnaire was used to collect information regarding the number of surgical procedures performed, types of hospital admissions, ti…

descriptive surveyDay surgerycataract surgery
researchProduct

Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease [2]

2002

Settore MED/16 - ReumatologiaRecurrenceSettore MED/30 - Malattie Apparato VisivoAntirheumatic AgentsBehcet SyndromeRetinitisAntibodies MonoclonalInfliximab
researchProduct